“Molecular Docking Studies of Salubrinal and Its Analogs As Inhibitors of the GADD34:PP1 Enzyme”. ADMET and DMPK, vol. 7, no. 2, Apr. 2019, pp. 140-5, https://doi.org/10.5599/admet.632.